IRONDisc MedicineIRON info
$63.50info-2.31%24h
Global rank6154
Market cap$1.53B
Change 7d-2.76%
YTD Performance10.96%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Disc Medicine (IRON) Stock Overview

    Disc Medicine, Inc., together with its subsidiaries, operates as a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.

    IRON Stock Information

    Symbol
    IRON
    Address
    321 Arsenal StreetWatertown, MA 02472United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.discmedicine.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    617 674 9274

    Disc Medicine (IRON) Price Chart

    -
    Value:-

    Disc Medicine Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $63.50
    N/A
    Market Cap
    $1.53B
    N/A
    Shares Outstanding
    24.14M
    N/A
    Employees
    60.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org